執(zhí)照.jpg)
白術(shù)內(nèi)酯Ⅰ
分析標(biāo)準(zhǔn)品,HPLC≥98%
Atractylenolide I
CAS號(hào)：73069-13-3
分子式：C15H18O2
分子量：230.3
MDL：MFCD09037395
貨號(hào) | 規(guī)格/參數(shù)/品牌 | 價(jià)格 | 貨期 |
YJ-B20054-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥1000.00 | 現(xiàn)貨 |
YJ-B20054-100mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥2500.00 | 現(xiàn)貨 |
A10279-20mg | 分析標(biāo)準(zhǔn)品,含量99.8%，可溯源 | ￥1280.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點(diǎn)：108-110℃（石油mi-乙酸乙酯）
沸點(diǎn)：405℃ at 760 mmHg
比旋光度：(c, 0.01 in MeOH)+222
外觀：白色針狀結(jié)晶
溶解性：DMSO：20mg/ml
儲(chǔ)存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)*威性，僅供客戶參考交流研究之用。
參考文獻(xiàn)(31篇)
31. [IF=2.5] Ya Gao et al."Atractylenolide-I Ameliorates Motor Deficits and Reduces Inflammation of the Spinal Cord by SIRT1/PGC-1α Pathway in MPTP Subacute Mouse Model of Parkinson’s Disease."Neuropsychiatric Disease and Treatment.
30. [IF=14.3] Xietao Ye et al."Monocyte/Macrophage-Mediated Transport of Dual-Drug ZIF Nanoplatforms Synergized with Programmed Cell Death Protein-1 Inhibitor Against Microsatellite-Stable Colorectal Cancer."Advanced Science.2024 Aug;:2405886
29. [IF=6.7] Yan Sun et al."Zexieyin formula alleviates Alzheimer's disease via post-synaptic CaMKII modulating AMPA receptor: Involved in promoting neurogenesis to strengthen synaptic plasticity in mice hippocampus."PHYTOMEDICINE.2024 Aug;131:155802
28. [IF=7.9] Mengwei Wang et al."Atractylenolide-I Alleviates Hyperglycemia-Induced Heart Developmental Malformations through Direct and Indirect Modulation of the STAT3 Pathway."PHYTOMEDICINE".2024 Jul;129:155698
27. [IF=2] Ying Tang et al."Geographical Origin Traceability of Atractylodes macrocephala Koidz. Using Mass Spectrometry Data Fusion and Ensemble Learning."ANALYTICAL LETTERS.10.1080/00032719.2024.2323074
26. [IF=1.8] Yue Qian et al."Si Miao San relieves hyperuricemia by regulating intestinal flora."BIOMEDICAL CHROMATOGRAPHY.2023 Dec;:e5807
25. [IF=3.4] Jiaxin Yin et al."Comprehensive multicomponent characterization and quality assessment of Xiaoyao Wan by UPLC-Q-Orbitrap-MS, HS-SPME-GC-MS and HS-GC-IMS."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2024 Feb;239:115910
24. [IF=5.2] Zhixing Gu et al."Simultaneous Analysis of Hydrophobic Atractylenolides, Atractylon and Hydrophilic Sugars in Bai-Zhu Using a High-Performance Liquid Chromatography Column Tandem Technique."Foods.2023 Jan;12(21):3931
23. [IF=4.6] Hailong Qiu et al."Geoherbalism Metabolomic Analysis of Atractylodes lancea (Thunb.) DC. by LC-Triple TOF-MS/MS and GC-MS."MOLECULES.2023 Jan;28(16):5974
22. [IF=4.9] Zhang Min et al."Discovery and evaluation of active compounds from Xuanfei Bai du formula against COVID -19 via SARS-CoV-2 Mpro."Chinese Medicine.2023 Dec;18(1):1-14
21. [IF=3.246] Yue Qian et al."A Network Pharmacology Method Combined with Molecular Docking Verification to Explore the Therapeutic Mechanisms Underlying Simiao Pill Herbal Medicine against Hyperuricemia."Biomed Research International.2023;2023:2507683
20. [IF=5.168] Pan Wang et al."Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay."CHEMICO-BIOLOGICAL INTERACTIONS.2022 Nov;367:110199
19. [IF=4.759] Gao-Yan Tong et al."Analysis of active compounds and geographical origin discrimination of Atractylodes macrocephala Koidz. by using high performance liquid chromatography-diode array detection fingerprints combined with chemometrics."JOURNAL OF CHROMATOGR
18. [IF=3.205] Jie Tang et al."Metabolite profiling of Shuganzhi tablets in rats and pharmacokinetics study of four bioactive compounds with liquid chromatography combined with electrospray ionization tandem mass spectrometry."J Chromatogr B. 2021 Aug;1179:122827
17. [IF=4.032] Qiu-yue Xiao et al."A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease."Exp Gerontol. 2021 Jul;149:111336
16. [IF=4.36] Xiaoli Zhao et al."Transcriptomic study of the mechanism by which the Kai Yu Zhong Yu recipe improves oocyte quality in a stressed mouse model."J Ethnopharmacol. 2021 Oct;278:114298
15. [IF=4.96] Yangyang Guo et al."Inhibition of proliferation-linked signaling cascades with atractylenolide I reduces myofibroblastic phenotype and renal fibrosis."Biochem Pharmacol. 2021 Jan;183:114344
14. [IF=3.935] Qian Wang et al."Content determination of the major constituents of Yinchenzhufu decoction via ultra high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry."J Pharmaceut Biomed. 2013 Apr;77:88
13. Wang, Qian, et al. "Content determination of the major constituents of Yinchenzhufu decoction via ultra high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry." Journal of pharmaceutical and biomedical analysis
12. Wang, Qian, et al. "Content determination of the major constituents of Yinchenzhufu decoction via ultra high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry." Journal of pharmaceutical and biomedical analysis
11. 李琴瑜, 吳衛(wèi)剛, 崔波, et al. 高效液相色譜法結(jié)合多元統(tǒng)計(jì)分析用于蒼術(shù)藥材的質(zhì)量評(píng)價(jià)[J]. 藥物分析雜志, 2018, v.38(04):56-66.
10. 陳文婷, 陳陽, 崔波,等. 氣相色譜"一測(cè)多評(píng)"用于蒼術(shù)多成分含量測(cè)定的可行性研究[J]. 中國中藥雜志, 2018, 043(003):551-556.
9. 丁逸雪 徐繼校 吳威 等. HPLC法同時(shí)測(cè)定白術(shù)中4種倍半萜[J]. 中成藥 2020 042(004):927-931.
8. 李春花, 李佳佳, 頓佳穎,等. 提取-共沸精餾耦合技術(shù)提取白術(shù)、桂枝揮發(fā)油工藝優(yōu)化[J]. 中成藥, 2019, 41(05):1132-1135.
7. 歐陽麗敏, 王新宏, 朱思敏,等. 基于AHP-CRITIC法探討英山茅蒼術(shù)最*佳采收期[J]. 中成藥, 2020, 042(003):708-713.
6. 李紅英,龍瀾,程新華,李亞杰,黃建民,帥超群.白術(shù)藥材中白術(shù)內(nèi)酯Ⅰ和白術(shù)內(nèi)酯Ⅲ含量的測(cè)定[J].湖北民族學(xué)院學(xué)報(bào)(自然科學(xué)版),2013,31(02):142-144.
5. 王建成. 白術(shù)中白術(shù)內(nèi)酯Ⅰ,Ⅱ,Ⅲ提取工藝優(yōu)選[J]. 中國實(shí)驗(yàn)方劑學(xué)雜志, 2015.
4. 張東 周其.HPLC法測(cè)定白術(shù)藥材中白術(shù)內(nèi)酯Ⅰ和白術(shù)內(nèi)酯Ⅲ含量[J].北方藥學(xué) 2017 14(03):1-2.
3. 鄧頌, 王愛萍, 陳曦,等. 黃芪白術(shù)湯下調(diào)miR-31-5p/STAT3環(huán)路抑制結(jié)腸炎相關(guān)性結(jié)腸癌進(jìn)程[J]. 中國藥理學(xué)通報(bào), 2019, v.35(09):134-139.
2. 沈建濤, 張振凌. 白術(shù)炮制品中白術(shù)內(nèi)酯Ⅰ、Ⅲ含量隨放置時(shí)間變化的研究[J]. 時(shí)珍國醫(yī)國藥, 2014, 025(008):1873-1875.
1. 邸思蓉 王雪 王燦燦 等. HPLC法同時(shí)測(cè)定肝炎康散中四種有效成分及指紋圖譜研究[J]. 沈陽藥科大學(xué)學(xué)報(bào) 2019 36(04):308-314.
從2011年開始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤色服務(wù)，協(xié)助客戶各類實(shí)驗(yàn)服務(wù)及論文潤色十余年，是客戶您值得信賴的科研合作伙伴!
如果您受時(shí)間、試驗(yàn)條件等限制而無法完成您的課題研究，歡迎您與我們聯(lián)系。
實(shí)驗(yàn)技術(shù)服務(wù)：
